A detailed history of Great Lakes Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 470,092 shares of PCRX stock, worth $9.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
470,092
Holding current value
$9.15 Million
% of portfolio
0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$11.7 - $28.46 $5.5 Million - $13.4 Million
470,092 New
470,092 $7.08 Million
Q2 2022

Aug 09, 2022

SELL
$51.49 - $81.64 $312,956 - $496,207
-6,078 Reduced 3.82%
153,238 $8.93 Million
Q1 2022

May 06, 2022

SELL
$60.03 - $76.49 $2.25 Million - $2.87 Million
-37,564 Reduced 19.08%
159,316 $12.2 Million
Q4 2021

Feb 09, 2022

SELL
$47.97 - $62.21 $197,060 - $255,558
-4,108 Reduced 2.04%
196,880 $11.8 Million
Q3 2021

Nov 09, 2021

SELL
$54.64 - $61.3 $391,550 - $439,275
-7,166 Reduced 3.44%
200,988 $11.3 Million
Q2 2021

Aug 11, 2021

SELL
$59.18 - $69.99 $454,975 - $538,083
-7,688 Reduced 3.56%
208,154 $12.6 Million
Q1 2021

May 03, 2021

BUY
$59.31 - $78.82 $964,261 - $1.28 Million
16,258 Added 8.15%
215,842 $15.1 Million
Q4 2020

Feb 09, 2021

SELL
$50.47 - $66.26 $442,117 - $580,437
-8,760 Reduced 4.2%
199,584 $11.9 Million
Q3 2020

Nov 04, 2020

BUY
$51.97 - $63.0 $1.64 Million - $1.99 Million
31,591 Added 17.87%
208,344 $12.5 Million
Q2 2020

Aug 07, 2020

BUY
$30.8 - $52.47 $391,314 - $666,631
12,705 Added 7.74%
176,753 $9.27 Million
Q1 2020

May 08, 2020

SELL
$28.4 - $50.7 $6,106 - $10,900
-215 Reduced 0.13%
164,048 $5.5 Million
Q4 2019

Feb 07, 2020

BUY
$36.31 - $46.83 $5.96 Million - $7.69 Million
164,263 New
164,263 $7.44 Million
Q4 2017

Feb 08, 2018

SELL
$31.85 - $46.95 $3.89 Million - $5.73 Million
-122,083 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$35.7 - $39.5 $4.36 Million - $4.82 Million
122,083
122,083 $4.58 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.